Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer
Article in Cancers (November 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Cancers (November 2023)
Article in Clinical Pediatric Hematology-Oncology (April 2022)
Article in Journal of Surgical Research (August 2021)